To examine how the expression of Dkk3 changes in time during ischemic stroke and how it manages the Wnt/β-catenin pathway, we decided to employ curcumin, a well-known activator of Wnt/β-catenin signaling, to investigate its effect on Dkk3. The gene discussed is DKK3; the disease is ischemic stroke.